Learn / MDGL
NASDAQ: MDGL
Madrigal Pharmaceuticals (MDGL) stock, explained like you're 5
Madrigal Pharmaceuticals trades on the Nasdaq under the ticker MDGL. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 10.9 billion dollars.
- Ticker
- MDGL
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Large cap, about 10.9 billion dollars
Is Madrigal Pharmaceuticals a small, medium or large cap company?
Yes. Madrigal Pharmaceuticals is a large cap stock. Its market cap, which is the total value of all its shares, is about 10.9 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Madrigal Pharmaceuticals makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves MDGL stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- MDGL Stock In Focus Retail Traders Buzz Over M&A Speculation And Fresh Patents For Liver Drug (Stocktwits)
- Stock awards for 26 new hires vest in four yearly installments at Madrigal (Stock Titan)
- Did Genetic Response Data Just Shift Madrigal Pharmaceuticals (MDGL) Investment Narrative? (Simply Wall Street)
- UBS raises Madrigal Pharmaceuticals stock price target on F4 trial outlook (Investing.com)
- MDGL Nov 2026 680.000 call (MDGL261120C00680000) Stock Price, News, Quote & History (Yahoo! Finance Canada)
Follow MDGL in your daily brief
Each trading day at 5 PM ET we post what happened to Madrigal Pharmaceuticals and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow MDGL
Questions about Madrigal Pharmaceuticals stock
What does Madrigal Pharmaceuticals do?
Madrigal Pharmaceuticals trades on the Nasdaq under the ticker MDGL. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 10.9 billion dollars.
What is the ticker symbol for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals trades under the ticker MDGL on the Nasdaq.
What is Madrigal Pharmaceuticals's market cap?
Madrigal Pharmaceuticals is a large cap stock with a market cap of about 10.9 billion dollars.
How does Madrigal Pharmaceuticals make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves MDGL stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow MDGL stock every day?
Add MDGL to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.